Eric Topol, MD, executive vice president of Scripps Research and director of Scripps Research Translational Institute (IMAGE)

Scripps Research Institute

Eric Topol, MD, executive vice president of Scripps Research and director of Scripps Research Translational Institute

Caption

In the wake of the US government ordering the Chinese artificial intelligence company iCarbonX to divest its majority ownership stake in the Cambridge, Mass.-based company PatientsLikeMe, Eric Topol, M.D., of Scripps Research, argues for more, not less, collaboration between China and the U.S. on artificial intelligence development.

Credit

Scripps Research

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.